Strategic Expansion of Singapore’s Leading TCM Brand into Indonesia
Liangyi TCM Singapore, a modern Traditional Chinese Medicine (TCM) clinic brand established in Singapore, successfully completed its strategic Indonesia market entry visit from 14-18 April 2026 with full support and facilitation from Esin Group Jakarta Office.
Representatives from Liangyi TCM, including Ms. Lynn Gaojie, Mr. Xiaodong Jing, and Mr. Zhang Chenxun, visited Jakarta as part of their overseas expansion and market entry preparation into Indonesia’s rapidly growing healthcare and wellness industry. As a modernized TCM brand established in Singapore in 2016, Liangyi TCM is known for combining Traditional Chinese Medicine with a contemporary healthcare approach, offering services including acupuncture, sports injury management, women’s health, and pediatric wellness solutions.
The five-day business mission focused on regulatory consultation, strategic partnerships, business location assessments, government engagement, and operational planning — laying a strong foundation for Liangyi CM’s expansion into Indonesia.
A Comprehensive Indonesia Market Entry Program by Esin Group
As a leading Indonesia market entry and corporate advisory firm, Esin Group executed a fully integrated and tailored market entry strategy for Liangyi TCM, covering:
- Indonesia healthcare market advisory
- PT PMA and foreign investment structuring
- Government liaison and regulatory consultation
- Strategic partnership sourcing
- Mall and retail location surveys
- Licensing and operational planning
- Grant consultation and internationalization support
- Workforce and education ecosystem development
The engagement was specifically designed to support foreign healthcare and TCM businesses seeking expansion into Indonesia’s healthcare sector.
Day 1 – Strategic Advisory & Indonesia Market Entry Planning
The visit officially commenced on 14 April 2026 with Liangyi TCM’s arrival in Jakarta, followed by an in-depth strategic advisory and market entry consultation session hosted by Esin Group Jakarta Office.
During the session, Esin Group presented:
- Indonesia healthcare industry overview
- Foreign investment structure recommendations
- PT PMA incorporation strategy
- Licensing and compliance pathways
- Market entry feasibility analysis
- Operational expansion roadmap
The day also allowed both teams to align on Liangyi TCM’s long-term vision for Indonesia and discuss expansion strategies for scalable clinic operations across Jakarta and other major Indonesian cities.
Day 2 – South & West Jakarta Mall Surveys and Strategic Partnership Discussions
On 15 April 2026, Esin Group coordinated extensive business location surveys across South and West Jakarta, enabling Liangyi TCM to evaluate high-potential commercial spaces and retail traffic patterns.
The delegation visited several premium malls and lifestyle destinations, including:
- Plaza Senayan
- Pacific Place
- Lippo Mall Nusantara
- Gandaria City
These surveys enabled Liangyi TCM to evaluate consumer demographics, accessibility, mall traffic, operational feasibility, and expansion scalability within Jakarta’s premium retail landscape.
The day concluded with a strategic dinner meeting alongside representatives from the Singapore Business Federation (SBF), where discussions focused on:
- Market Readiness Assistance (MRA) Grant opportunities
- Overseas Market Immersion and Internship Programme (OMIIP)
- International expansion support initiatives
- Cost optimization strategies for overseas market entry
Day 3 — Government Engagement with Indonesia Ministry of Investment (BKPM)
One of the key highlights of the visit was a strategic meeting facilitated by Esin Group with Indonesia’s Ministry of Investment (BKPM), specifically the SEA, Australia, and New Zealand Investment Desk.
The session provided Liangyi TCM with:
- Direct regulatory insights
- Foreign investment advisory
- Healthcare business licensing guidance
- PT PMA structuring recommendations
- Indonesia healthcare market outlook
- Expansion and investment support information
The engagement demonstrated Indonesia’s openness toward international healthcare investment and reinforced Liangyi TCM’s confidence in entering the Indonesian market.
Afterwards, the team took time to check store unit availability in Central Park – West Jakarta.
Day 3 was concluded by providing a journey to North Jakarta, Pantai Indah Kapuk (PIK) area – allowing Liangyi to experience different corners of Jakarta.
Day 4 – Educational Partnerships and North Jakarta Expansion Surveys
On 17 April 2026, the Liangyi TCM delegation conducted another series of location surveys across North Jakarta, covering:
- Emporium Mall Pluit
- Mall Kelapa Gading
- Mall of Indonesia
These surveys formed part of Liangyi TCM’s broader strategy to identify scalable retail and healthcare expansion opportunities across different Jakarta regions.
Esin Group also facilitated discussions with Nalanda University regarding collaboration opportunities for Traditional Chinese Medicine study programs, practitioner development, and long-term workforce sustainability.
This initiative supports the development of:
- Local TCM practitioners
- Professional certification pathways
- Sustainable talent pipelines
- Long-term healthcare ecosystem growth in Indonesia
Tangible Business Outcomes Achieved During the Visit
The Indonesia business mission resulted in several concrete achievements for Liangyi TCM, including:
Key Achievements
- Successful signing of MOUs with three education and vocational partners
- Direct advisory engagement with Indonesia’s Ministry of Investment
- Offer letters secured from two prestigious Jakarta malls
- Local partner engagement for licensing and operational support
- Submission support for Singapore’s MRA Grant application
- Strategic consultation regarding SBF OMIIP Program participation
These milestones significantly accelerated Liangyi TCM’s readiness for Indonesia market entry.
Why Indonesia Is a Strategic Expansion Market for Healthcare and TCM Businesses
Indonesia presents compelling advantages for healthcare and wellness brands seeking regional expansion. Through Esin Group’s advisory and market intelligence support, Liangyi TCM identified several strategic benefits:
Lower Operational Costs Compared to Singapore
- Estimated Jakarta mall tenancy costs: SGD 45-50/sqm
- Living costs approximately 70-80% lower than Singapore
- Ability to operate multiple clinics at lower overhead costs
Scalable Workforce and Talent Availability
Indonesia offers a growing pipeline of licensed traditional healthcare practitioners under a regulated framework, enabling scalable expansion with a hybrid workforce strategy involving both local practitioners and foreign doctors.
Efficient Corporate and Tax Structuring
Esin Group advised on a scalable PT PMA holding structure that supports:
- Multi-outlet expansion
- Risk isolation between operational entities
- Centralized management
- Efficient dividend flow structure
- 0% withholding tax on dividends for corporate shareholders under Indonesian tax regulations
Supporting Liangyi TCM’s Vision for Indonesia
The successful visit demonstrates how structured market entry execution, local expertise, and strong ecosystem connections can significantly accelerate foreign business expansion into Indonesia.
With Esin Group’s support, Liangyi CM is now progressing toward its ambitious expansion target of establishing 15-20 outlets in Indonesia within the next two years.
As Indonesia continues to emerge as one of Southeast Asia’s most promising healthcare and wellness markets, Esin Group remains committed to helping international businesses successfully navigate investment, licensing, partnerships, and operational setup in Indonesia.
